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ORIGINAL INVESTIGATION
Accelerated growth of orbital schwannomas during pregnancy does not
correlate with sex hormone- or growth factor receptor status
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aDepartment of Oculoplastic, Orbital and Lacrimal Surgery, the Rotterdam Eye Hospital, Rotterdam, The Netherlands; bDepartment of
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Ophthalmology, Orbital Service, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands; dOculoplastic & Orbital
Service, ELZA Clinic, Zurich, Switzerland
ABSTRACT
Purpose: Until now, three cases of growth of an orbital schwannoma during pregnancy have
been published. We aim to provide additional insight in the effect of pregnancy on orbital
schwannomas.
Methods: We present two additional cases of accelerated growth of orbital schwannomas during
pregnancy and investigate receptor expression profiles for estrogen, progesterone, androgen,
VEGF, EGF, FGF, PDGF-Rβ and ki-67 in the two pregnant cases and six non-pregnant cases.
Results: Case 1: A 26-year-old woman developed unilateral exophthalmos during pregnancy, with
normal visual acuity and ocular motility. During a subsequent pregnancy, again the exophthalmos
progressed. MRI showed a mass suggestive of schwannoma. After delivery, resection of the lesion
was performed through an anterior approach. Pathology confirmed schwannoma. The expression
profile was positive for estrogen- and FGF receptors and ki-67, but negative for progesterone-,
androgen- and other growth factor receptors. Case 2: A 24-year-old woman presented with
diplopia and unilateral pain during pregnancy. She had normal visual acuity, but a mild
exophthalmos and elevation deficit. MRI revealed an extraconal mass suggestive of schwannoma.
After delivery, resection was performed through an anterior approach. Pathology confirmed the
diagnosis. The expression profile was positive for ki-67, but negative for sex hormone- and growth
factor receptors.
In the six non-pregnant cases the expression profiles varied, with only one subject showing
a strong expression of estrogen-, progesterone- and androgen receptors.
Conclusions: Orbital schwannomas can experience growth during pregnancy. The underlying
mechanism remains unclear as hormone- and growth factor expression profiles show no correla-
tion to the pregnant state.
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Introduction
Orbital schwannomas were first described by Verocay
in 1908. It is a rare benign neoplasm, accounting for
approximately 1% of all orbital tumors, and arises from
the myelin producing Schwann cells in peripheral
axons.1
Most orbital schwannomas originate from the
ophthalmic division of the trigeminal nerve and are
commonly located in the superior orbit due to the
nerve distribution pattern.2,3 It presents unilaterally,
although there has been one report of bilateral orbital
schwannoma.4 When small they are asymptomatic, but
usually tend to grow over months to years, causing
a slowly progressive exophthalmos and inferior
displacement.3,5 Other clinical symptoms are also aspe-
cific and include diplopia and motility disorders, visual
loss, scotomas and eyelid swelling.3 Although they are
usually painless, a deep, dull pain or sensibility disorder
may occur in the distribution of the affected nerve.3
Schwannomas are predominantly benign, and reported
cases of malignant transformation are controversial.5
Also, intracranial extension, most commonly through
the superior orbital fissure, can occur.2
Imaging characteristics are best appreciated on mag-
netic resonance imaging (MRI), with a hypointense
signal on T1 and a hyperintense signal on T2-
weighted images.3,5 The use of contrast agents may
show homogenous or heterogeneous enhancement.3,5
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Macroscopically, orbital schwannomas appear as
a vascularized, encapsulated mass.5 Histologically 5
subtypes are described: conventional-, cellular-, -, plexi-
form-, microcystic- and reticular schwannomas. Of
these, conventional schwannomas are by far the most
common type in the orbit.3 Longstanding tumors,
which are referred to as ancient schwannomas, may
also show degenerative changes such as hemorrhages,
cyst-like spaces and calcification.3–5 Typically, two
morphological patterns are noted, which are known as
Antoni A and Antoni B areas. The Antoni A pattern
shows closely packed spindle cells. The nuclei of Antoni
A cells may also show a palisading pattern, known as
Verocay bodies. In the Antoni B pattern, the spindle
cells are more loosely arranged within the stroma.2,3,5,6
Interestingly, Pointdujour-Lim et al found that the
Antoni B pattern corresponds to the lucent areas on
T1 and hyperintense areas on T2-weighted MRI.2
The typical histological patterns can aid in the dif-
ferentiation from other peripheral nerve sheath tumors.
Immunohistochemistry is generally not required, but
shows an intense diffuse staining profile for S-100.3,7,8
Treatment consists of surgical excision. As the
growth of schwannoma generally tends to displace the
normal nerve eccentrically, the schwannoma may be
dissected away from the involved nerve.2,5 If the lesion
is incompletely excised, local recurrence may occur.5,9
To date, only three cases have reported accelerated
growth of an orbital schwannoma during
pregnancy.10–12 Chang et al reported that the tumor
was positive for progesterone-, but not for estrogen
receptors.11 The case presented by Sugo et al was
negative for both progesterone- and estrogen recep-
tors and Birkholz et al did not test for hormone
receptor expression profiles.10,12 There are no reports
on expression of non-sex hormone growth factor
receptors for orbital schwannomas.
In this report we present two more cases of acceler-
ated growth of orbital schwannomas during pregnancy.
Also, we present receptor expression profiles for estro-
gen (ER), progesterone (PR), androgen (AR), vascular
endothelial growth factor (VEGF-R), epidermal growth
factor (EGF-R), fibroblast growth factor (FGF-R), pla-
telet-derived growth factor (PDGF-Rβ) and the prolif-
eration marker ki-67 and compare these to the
expression profiles of six non-pregnant cases.
Materials and methods
Following the principles of the Declaration of Helsinki,
the clinical course and expression profiles were evaluated
in two orbital schwannomas experiencing growth during
pregnancy. Additionally, in six non-pregnant cases the
same expression profiles were assessed.
Diagnosis of orbital schwannoma was made based
on histological characteristics, and incidental immu-
nohistochemical staining for S-100. The expression
profiles were evaluated for estrogen-, progesterone-,
androgen receptor and ki-67 (respectively clone SP1,
clone 1E2, clone SP107 and clone 30–9 from Ventana
Medical Systems, Tucson, Arizona, USA). Cut-off
levels for positive staining were arbitrarily put at
10% in analogy to generally accepted guidelines for
the interpretation of hormone receptor staining in
breast carcinoma. Likewise, receptor expression pro-
files were assessed for VEGF (clone SP28, abcam,
ab27620), EGF (clone 3C6, Ventana), FGF (polyclo-
nal, abcam, ab58201) and PDGF (receptor β, Santa
Cruz, sc339). For these stainings an immunoreactive
score (IRS) was determined as has been described in
a previous report.13 First, intensity of the staining was
classified as absent (0), mild (1), moderate (2) or
intense (3). Secondly, percentage of stained cells that
showed the predominant intensity was scored as no
positive cells (0), less than 10% (1), 10% to 50% (2),
51% to 80% (3), and more than 80% (4). Finally, the
IRS was determined as the product of intensity and
percentage scores, thereby ranging from 0 tot 12. Cut-
off levels for positive IRS were arbitrarily put at 4.
Results
Case 1
During pregnancy, a 26-year-old woman with a history of
hypothyroidism, had noted an exophthalmos of her left
eye and swelling of the left upper eyelid. After delivery of
an unviable fetus, she was referred for further evaluation.
Examination revealed an exophthalmos of 4 mm with
inferior displacement of the globe (Figure 1a). Visual
acuity and ocular motility were normal. There were no
clinical signs of active Graves orbitopathy and both thyr-
oid stimulating hormone (TSH) and fT4 were normal,
although anti-TSH receptor antibodies were slightly ele-
vated. No stigmata of neurofibromatosis were identified
and no other neurological abnormalities were found.
MRI showed a well-defined cystic mass of 3.2 × 1.5 cm
with fluid levels. The lesion was located intraconally,
extending to the extraconal space. The lesion showed
contrast enhancement of the capsule only (Figure 1b).
With the findings explained as cystic degeneration, the
tumor was found most likely to be a schwannoma.
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Surgical excision was postponed because of a new
pregnancy. During this pregnancy, the lesion again
showed signs of growth with the exophthalmos reach-
ing 8 mm. Also, now there were complaints of obscura-
tions in left gaze and a dull pain. After pregnancy,
surgical resection was performed through a trans lid
approach (Figure 1c). Post-operatively, examination
showed no exophthalmos and normal visual acuity
and ocular motility (Figure 1d). Also, there was no
impairment of facial sensibility.
Histopathology revealed mainly areas of closely
packed spindle cells, typical for the Antoni A pattern
of schwannoma, and fewer areas of the Antoni
B pattern (Figure 2a). Immunohistochemical studies
showed that the tumor was diffusely and strongly posi-
tive for S-100, confirming the diagnosis (Figure 2b).
Case 2
A 24-year-old pregnant woman with no medical history
presented with diplopia and pain of her right eye since
the 19th week of gestation. Examination showed
a 2 mm exophthalmos of the right eye with inferior
displacement of the globe. Orthoptic evaluation
revealed a mild elevation deficit of the right eye.
Visual acuity was normal. No neurological abnormal-
ities were found and there was no family history of
neurofibromatosis.
MRI was performed without contrast imaging and
showed an extraconal mass of the right orbit (Figure 3a).
The 3.5 × 2 cm solid mass was located lateral to the super-
ior rectusmuscle and gave pressure to the levator palpebrae
and superior rectus muscles. Based on these findings, the
Figure 1. Case 1 (a) Pre-operative examination showed exophthalmos and inferior displacement of the left globe (b) T1-weighted
MRI shows a well-defined cystic mass with contrast enhancement of the capsule only. (c) Intra-operative appearance of the
schwannoma. (d) Post-operative examination showed no globe displacement.
Figure 2. Case 1 (a) Hematoxylin-Eosin stain shows areas of tightly packed spindle cells (Antoni A) and areas of more loosely
organized spindle cells (Antoni B). (B) Immunohistochemistry shows strong positive staining for S-100 protein.
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lesion was suspected to be a schwannoma or cavernous
hemangioma.
After an uneventful (term) delivery, surgical resec-
tion by a trans lid approach was performed. The tumor
surrounded the supraorbital nerve, but could be
resected completely (Figure 3b). Post-operatively, she
experienced hypoesthesia in the region of the supraor-
bital nerve. Ocular motility and visual acuity were nor-
mal and there was no more exophthalmos.
Histopathology revealed abundant spindle cells and pre-
dominantly Antoni-A features. Immunohistochemical stu-
dies revealed a diffuse and strong positive staining for
S-100 protein.
Expression profiles for ER, PR, AR, VEGF-R,
EGF-R, FGF-R, PDGF-Rβ and ki-67
For all eight cases the expression profiles for ER, PR,
AR, VEGF-R, EGF-R, FGF-R, PDGF-Rβ and ki-67 are
depicted in Table 1.
In the first pregnant case, staining was negative for PR
and AR but slightly positive for ER (Figure 4a–c).
Conversely, the second pregnant case showed to be nega-
tive for all three sex hormone receptors (Figure 4i–k). Of
the six non-pregnant subjects, the staining profiles
showed mixed results, with one female case highly posi-
tive for ER, PR and AR (Figure 4q–s).
For the growth factors, only FGF-R came out posi-
tive in the first pregnant case (Figure 4d–g), while none
were positive in the second pregnant case (Figure 4l–o).
Again, results for the non-pregnant cases were mixed.
Ki-67 was positive in both pregnant cases (Figure 4h,p),
but in only one non-pregnant case.
Discussion
The levels of estrogen and progesterone show a steady
increase during pregnancy until the moment of deliv-
ery. Some orbital neoplasms such as cavernous heman-
giomas, solitary fibrous tumors and meningiomas, have
shown a tendency to grow due to these hormonal
changes or by the use of hormonal medication.14–18 In
cavernous hemangioma, the tendency to grow during
pregnancy could be explained by the expression of
progesterone receptors.19,20 Moreover, for the acoustic
schwannoma, growth during pregnancy has also been
reported, but a correlation between progesterone- and
estrogen receptor expression and proliferative activity
could not be demonstrated.21–24
Figure 3. Case 2 (a) T1-weighted MRI without contrast shows an extraconal mass superior in the right orbit. (b) Intra-operative
appearance of the schwannoma surrounding the supraorbital nerve.
Table 1. Expression profiles.
Gender ER PR AR VEGF-R EGF-R FGF-R PDGF-Rβ ki-67
Pregnant case 1 F 10 0 2 1 0 4 3 15
Pregnant case 2 F 2 1 0 0 0 0 1 10
Non-pregnant case 1 M 10 0 25 0 4 2 2 8
Non-pregnant case 2 F 95 95 95 2 12 4 3 2
Non-pregnant case 3 M 1 20 12 1 4 2 2 8
Non-pregnant case 4 M 12 60 60 1 2 4 4 2
Non-pregnant case 5 F 1 0 5 2 9 9 3 8
Non-pregnant case 6 F 10 20 25 0 8 4 8 15
Expression rate 5/8 (62.5%) 4/8 (50%) 5/8 (62.5) 0/8 (0%) 5/8 (62.5) 5/8 (62.5%) 2/8 (25%) 3/8 (37.5%)
ER = Estrogen Receptor; PR = Progesterone Receptor; AR = Androgen Receptor; VEGF-R = Vascular Endothelial Growth Factor Receptor; EGF-R = Epidermal
Growth Factor Receptor; FGF-R = Fibroblast Growth Factor Receptor; PDGF-Rβ = Platelet-derived Growth Factor Receptor-β.
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On the other hand, vascular changes, possibly
related to the expression of VEGF, have been shown
to be an additional causative mechanism for growth of
meningiomas during pregnancy.25,26 Also, the expres-
sion of other growth factor receptors, such as FGF-R
and PDGF-Rβ, may be involved.27
For orbital schwannoma it is unclear what may
cause excessive growth during pregnancy and little is
known about receptor expression of these tumors. To
date, three cases have reported accelerated growth of
an orbital schwannoma during pregnancy.10–12 In their
patient, Chang et al reported that the tumor was posi-
tive for progesterone-, but not for estrogen receptors.
Based on this observation, they concluded that growth
during pregnancy was to be explained by the expres-
sion of these progesterone receptors.12 On the other
hand, the case presented by Sugo et al was negative for
both progesterone- and estrogen receptors. As such,
they suggested that another factor, such as intratu-
moral hemorrhage, may have explained the accelerated
growth. They state that this assumption was supported
by the presence of erythrocyte components in the cys-
tic fluid.11 Indeed, schwannomas are known to be
highly vascularized, putting them at risk for such intra-
tumoral hemorrhage. However, the presence of ery-
throcyte components is a normal finding in
schwannomas and does not further support their
hypothesis. Unfortunately, Birkholz et al did not test
for the expression of hormone receptors in their
patient.10
In this report we have evaluated the receptor expres-
sion profiles for sex hormones (ER, PR and AR),
growth factors (VEGF-R, EGF-R, FGF-R, PDGF-Rβ)
and the proliferation marker ki-67 in two pregnant
and six non-pregnant subjects with orbital
schwannomas.
For the expression of sex hormone receptors, our
first pregnant case showed expression of only ER, while
the second case was negative for all three hormone
receptors. One control case however, did show highly
increased expression of all three hormone receptors. As
such, our series fail to show a direct correlation
between the receptor expression profiles of ER, PR
and AR and the tendency to grow during pregnancy.
When looking at the expression of growth factor
receptors, the first pregnant case showed expression of
only FGF-R, while again, the second case was negative
for all four growth factor receptors. In the non-
pregnant cases the results were mixed, with EGF-R
and FGF-R being most predominantly expressed.
Again, no correlation can be drawn between these
expression profiles and the accelerated growth during
pregnancy.
As suggested by Sugo et al, other factors that may
explain the sudden growth should be sought.11
Nevertheless, especially the first case (with a positive
expression of ER and FGF-R) is an interesting one, as
she experienced tumor growth during two sequential
pregnancies without signs of intratumoral hemorrhage.
Also, as ki-67 is cellular marker for proliferation, the
positive expression of ki-67 in both pregnant cases
implicates an active proliferative state at the time of
surgery.28 Interestingly, of the six non-pregnant cases,
one case showed a very strong expression of all three
sex hormone and EGF receptors, but no expression of
ki-67. It must be said, however, that there was no
indication about recent growth in the non-pregnant
subjects, which may explain low ki-67 expression in
Figure 4. Staining profiles for receptors. ER = Estrogen Receptor; PR = Progesterone Receptor; AR = Androgen Receptor; VEGF-R
= Vascular Endothelial Growth Factor Receptor; EGF-R = Epidermal Growth Factor Receptor; FGF-R = Fibroblast Growth Factor
Receptor; PDGF-Rβ = Platelet-derived Growth Factor Receptor-β.
(a–h) For the first pregnant case, staining was slightly positive for ER (a), FGF-R (f) and ki-67 (h).(i–p) For the second pregnant case, staining
was slightly positive for ki-67 only (p).(q–x) In one non-pregnant case, also female, staining was strongly positive for ER (q), PR (r), AR (s) and
EGF-R (u) and slightly positive for FGF-R (v)
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these cases. This limits the value of our comparison
between pregnant and non-pregnant cases.
Overall, the expression rates were 62.5% for ER, 50%
for PR, 62.5% for AR, 0% for VEGF-R, 62.5% for EGF-
R, 62.5% for FGF-R, 25% for PDGF-Rβ and 37.5% for
ki-67. Moreover, no evident difference in staining pat-
terns could be identified when looking at male and
female subjects separately.
In conclusion, orbital schwannomas can show accel-
erated growth during pregnancy, which has been sug-
gested to be associated with sex hormone receptor
expression. Our current series show no correlation
between tumor growth during pregnancy and receptor
expression profiles of ER, PR, AR, VEGF-R, EGF-R,
FGF-R and PDGF-Rβ, although the expression of ki-
67 does implicate an active proliferative state of these
tumors.
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